Home > Pressrelease > Infection Control Supplies Market size to exceed $54bn by 2030

Infection Control Supplies Market size to exceed $54bn by 2030

  • Published Date: August 23, 2022

Infection Control Supplies Market size is projected to cross USD 54 billion by 2030, according to a new research report by Global Market Insights Inc.
 

The report identifies the increasing prevalence of chronic illnesses as one of the prominent growth drivers of the infection control supplies industry. Chronic diseases such as diabetes, high blood pressure, kidney diseases, and cancer are observing increasing prevalence over recent years. The National Council on Aging, Inc reveals that nearly 80% of adults more than or equal to 65 years of age had at least one chronic disease in 2021, with about 68% having two or more chronic disorders. The growing disease burden has led to prolonged hospital stays, significantly pushing the demand for infection control supplies over the forecast period.
 

Increasing application across healthcare facilities to push the demand for disinfectants

With respect to the products category, disinfectants held a revenue share of more than 13 billion in 2021. The segment expansion can be credited to the increasing utilization of chemical disinfectants such as glutaraldehyde, hydrogen peroxide, and formaldehyde across hospital and clinical settings. In addition, the growing health concerns, and rising patient awareness towards maintaining proper hygiene during their hospital stay may further stimulate the infection control supplies market forecast from disinfectants.
 

Wholesalers to gain popularity as a major distribution channel

The report cites wholesalers to emerge as a prominent distribution channel over the assessment timeframe. The infection control supplies industry size from wholesalers exceeded USD 8 billion in 2021. Wholesalers help in the large-scale manufacture and distribution of products while significantly improving the supply chain efficiency of the enterprises. Given that they cater to a broad spectrum of large corporations such as hospitals and other healthcare facilities due to their capability of storing products in bulk quantities at their warehouses, wholesalers are likely to gain momentum in the forthcoming years.
 

Browse key industry insights spread across 302 pages with 463 market data tables & 16 figures & charts from the report, “Infection Control Supplies Market Analysis By Product (Disinfectant [By Product Type {Surface Disinfectant, Skin Disinfectant, Instrument Disinfectant, Hand Disinfectant}, By Formulation {Disinfectant Sprays , Disinfectant Wipes, Liquid Disinfectants}, By EPA Classification {Low-Level Disinfectants, Intermediate-Level Disinfectants, High-Level Disinfectants}], Disinfection and Cleaning Accessories, Cleaning and Disinfection [Ultrasonic Cleaners, Flusher Disinfectors, UV-Ray Disinfectors, Washer Disinfectors, Others], Disposable Safety Products [Surgical Drapes and Gowns, Face Masks, Goggles, Gloves, Covers and Closures]), By Distribution Channel (Wholesalers, Retailers, Pharmacies, E-commerce), By End-use (Hospitals & Clinics, Medical Device Companies, Pharmaceutical Companies, Research Laboratories), Industry Analysis Report, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/infection-control-supplies-market

 

Stringent regulations to drive the product demand across medical device companies

Medical device companies are projected to account for over 13% of the market share until 2030. This can be credited to the presence of a strict regulatory framework for infection control across healthcare settings. The increasing number of sterilization products gaining approval from authoritative bodies may also fuel the market expansion.
 

Huge investments to aid the industry growth across the Asia Pacific

Asia Pacific infection control supplies market may exhibit noteworthy growth trends during the projection period. The regional growth is driven by the increasing public-private investments aimed at generating awareness about infection control and prevention and substantially growing medical non-woven product sales. The emergence of several new players in the region and their increasing focus on acquiring a significant market share may push the regional industry revenue.
 

Partnerships to emerge as a prominent growth strategy

Top companies participating in the competitive landscape of the infection control supplies market include 3M, Cardinal Health, Getinge Ab, Advanced Sterilization Products (ASP), Ecolab, Steelco S.p.A, Steris Plc, Belimed Deutschland GmbH (Metal Zug Group), Matachana Group, Henry Schein, Dentsply Sirona, and Metrex Research, LLC (Envista Holdings Corporation). These companies have been implementing several growth strategies such as mergers, collaborations, partnerships, and acquisitions to extend their product offerings and meet the demand of a widely expanding customer base.
 

For instance, in September 2021, Ecolab Inc joined hands with Sodexo to develop novel infection prevention offerings to cater to the growing requirements of hospitals and healthcare facilities across the US. The move was intended to reinforce the product offerings while enhancing the development capabilities of both companies in the market.
 

Authors: Sumant Ugalmugle, Rupali Swain